LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 24.09 | 27.76 | 1122 | 1461 | 0.7676 | 0.9096 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 25.79 | 27.76 | 905 | 1605 | 0.5638 | 0.8135 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 25.79 | 27.76 | 1037 | 1605 | 0.6461 | 0.8562 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 25.79 | 27.76 | 1024 | 1605 | 0.6380 | 0.8522 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 25.79 | 27.76 | 1134 | 1605 | 0.7065 | 0.8847 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 27.49 | 27.76 | 958 | 1723 | 0.5560 | 0.8123 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 27.49 | 27.76 | 1054 | 1723 | 0.6117 | 0.8416 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 27.49 | 27.76 | 1088 | 1723 | 0.6314 | 0.8514 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 27.49 | 27.76 | 1172 | 1723 | 0.6802 | 0.8747 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 29.19 | 27.76 | 990 | 1863 | 0.5314 | 0.8021 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 29.19 | 27.76 | 1083 | 1863 | 0.5813 | 0.8290 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 29.19 | 27.76 | 1123 | 1863 | 0.6027 | 0.8399 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 29.19 | 27.76 | 1195 | 1863 | 0.6414 | 0.8589 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 30.90 | 27.76 | 1029 | 2032 | 0.5063 | 0.7919 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 30.90 | 27.76 | 1112 | 2032 | 0.5472 | 0.8145 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 30.90 | 27.76 | 1170 | 2032 | 0.5757 | 0.8294 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 30.90 | 27.76 | 1247 | 2032 | 0.6136 | 0.8483 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 32.60 | 27.76 | 1044 | 2235 | 0.4669 | 0.7734 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 32.60 | 27.76 | 1153 | 2235 | 0.5157 | 0.8014 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 32.60 | 27.76 | 1156 | 2235 | 0.5170 | 0.8021 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 32.60 | 27.76 | 1265 | 2235 | 0.5658 | 0.8280 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 34.30 | 27.76 | 1082 | 2449 | 0.4417 | 0.7625 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 34.30 | 27.76 | 1166 | 2449 | 0.4760 | 0.7830 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 34.30 | 27.76 | 1185 | 2449 | 0.4837 | 0.7874 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 34.30 | 27.76 | 1331 | 2449 | 0.5433 | 0.8199 | MN20160318_Q01 | G04 |